Detalhe da pesquisa
1.
Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection.
J Infect Dis
; 227(11): 1303-1312, 2023 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484441
2.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065705
3.
Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
J Infect Dis
; 225(2): 327-331, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34888662
4.
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
Lancet
; 397(10275): 682-694, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524311
5.
Persistence of the Immune Responses and Cross-Neutralizing Activity With Variants of Concern Following 2 Doses of Adjuvanted SCB-2019 Coronavirus Disease 2019 Vaccine.
J Infect Dis
; 224(10): 1699-1706, 2021 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480575
6.
Maternal immunization: opportunities for scientific advancement.
Clin Infect Dis
; 59 Suppl 7: S408-14, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425719
7.
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414.
BMC Pediatr
; 14: 295, 2014 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433534
8.
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
Hum Vaccin Immunother
; 20(1): 2301632, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206168
9.
Immunogenicity, reactogenicity, and safety of a human rotavirus vaccine, Rotarix, in Taiwanese infants who received a dose of hepatitis B immunoglobulin after birth.
J Formos Med Assoc
; 112(9): 574-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24079716
10.
Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study.
Vaccine
; 41(11): 1875-1884, 2023 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781334
11.
Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12-17 year-old adolescents.
Hum Vaccin Immunother
; 19(1): 2206359, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226504
12.
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.
BMC Infect Dis
; 12: 213, 2012 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22974466
13.
Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.
Lancet Infect Dis
; 22(7): 990-1001, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447085
14.
Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 °C for seven days.
Hum Vaccin
; 7(1): 74-80, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21228629
15.
Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.
Southeast Asian J Trop Med Public Health
; 42(1): 138-47, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21323176
16.
Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
J Infect Dis
; 202 Suppl: S80-6, 2010 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20684722
17.
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial.
Lancet Infect Dis
; 21(9): 1282-1292, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019802
18.
Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial.
Vaccine
; 38(33): 5313-5323, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32563609
19.
The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability.
Pediatr Infect Dis J
; 28(3): 225-32, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19209095
20.
Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
Pediatr Infect Dis J
; 28(4): 261-6, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289978